The slip
PARKINSON RECEIPTno. 15703
31 Oct 2026, 01:38 UTCdopamine neurons, braak
predictionMYO19 in dopamine neurons tracks Braak Lewy-body stage
registeredcdce88e199c15d07
discovery-0.70 p=0.035 n=9
replication+0.09 p=0.813 n=9
neededp < 0.05 twice, same sign
did not replicate (discovery -0.70 p 0.035; held-out +0.09 p 0.813)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
DID NOT REPLICATEedcbc55590ac834ee1db4eb8…
follows 42fc961f744d…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 15703: MYO19 in dopamine neurons, braak
- power
- full sample -0.34 (p 0.167, n 18), 95% CI -0.70 to +0.15. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.34 (p 0.173, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.42 (p 0.082, n 18). could be the mix.
- skeptic
- leave-one-out range -0.48 to -0.25, sign flips 0; without severely affected donors -0.34 (p 0.167, n 18). fragile.
- cell type
- strongest in OPCs: -0.75 (p 3.7e-4, n 18) vs -0.34 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for MYO19 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up MYO19 · OPCs · braak: substantia nigra, an independent cohort (already registered)